Treating metastatic non-small cell lung cancer (NSCLC) patients with the immunotherapy drug pembrolizumab after they've completed locally ablative therapy—meaning all known sites of their cancer were either treated with ...
Jul 11, 2019
0
5
Immune checkpoint blockade therapies have been revolutionary in the treatment of some cancer types, emerging as one of the most promising treatments for diseases such as melanoma, colon cancer and non-small cell lung cancer.
May 15, 2023
0
74
A new editorial paper was published in Oncoscience, titled "Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer."
Oct 6, 2023
0
47
Metastasis, the process by which cancer spreads beyond its site of origin, is associated with poor clinical prognosis, cancer mortality, and resistance to therapy. Non-small cell lung cancer (NSCLC) in particular, has a high ...
Feb 17, 2023
0
12
Research shows that inhibiting necroptosis, a form of cell death, could be a novel therapeutic approach for treating chronic obstructive pulmonary disease (COPD), an inflammatory lung condition, also known as emphysema, that ...
Jun 17, 2021
0
8
A variant of the CTLA-4 gene associated with autoimmune disease was found to be more frequent in non-small cell lung cancer (NSCLC) patients who experienced an exceptionally high response to anti-PD-1 immunotherapy and higher ...
Apr 11, 2022
0
11
Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many times, a hallmark of cancer ...
May 2, 2024
0
42
A pair of stem cell cloning experts at the University of Houston is reporting their findings of variant cells in the lungs of patients with idiopathic pulmonary fibrosis (IPF) which likely represent key targets in any future ...
May 17, 2023
0
45
Researchers at the Spanish National Cancer Research Centre (CNIO), led by Dr. Manuel Valiente, have uncovered how cancer cells that have spread to the brain (metastasis) are able to resist the effects of radiotherapy. The ...
Apr 11, 2022
0
65
Chinese scientists recently reported the key role in tumor survival played by a histone-acetylation-regulated long noncoding RNA called lysosome cell death regulator (LCDR), providing a potential diagnostic and therapeutic ...
Jan 17, 2022
0
8
